Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PBLS compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
PBLS
Parabilis Medicines, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
PBLS
Parabilis Medicines, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Event sensitivity
Desk
News
Calendar
Saved
Search
Event sensitivity
release-day history · min 6 releases
Method
›
Insufficient release history: PBLS.
PBLS
Parabilis Medicines, Inc.
Change
27.87
▼
−8.19%
· post 27.87
· delayed
Mkt cap
$806.0M
Revenue
$148,000
Q2 FY26
Revenue
—
LLY
ELI Lilly & Co
Change
1,371.32
▼
−3.29%
· post 1,361.00
· delayed
After hours
Nov 5 '26
delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
After hours
Nov 5 '26
delayed
PBLS
Parabilis Medicines, Inc.
vs
LLY
ELI Lilly & Co
27.87
▼
−8.19%
post 27.87
delayed
Price
1,371.32
▼
−3.29%
post 1,361.00
delayed
$806.0M
Mkt cap
$1.3T
Q2 FY26
$148,000
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
PBLS
27.87
▼
−8.19%
vs
LLY
1,371.32
▼
−3.29%
After hours
Nov 5 '26
delayed